ClinicalTrials.gg
Status unknownNCT04429997Updated Aug 31, 2021

Incidence of Patellar Crepitus in Removal and Non-removal of Fibrosynovial Tissue at Superior Pole of Patella

An interventional study of Removal of fibrosynovial tissue and Non-removal of fibrosynovial tissue in Removal of Fibrosynovial Tissue, Non-removal of Fibrosynovial Tissue and Patellar Non-resurfacing, sponsored by Navamindradhiraj University. Status unknown at 1 site in Thailand. Per ClinicalTrials.gov, last updated 2021-08-31.

Sponsored by Navamindradhiraj University · Not applicable, Interventional, and Diagnostic

How we know

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to compare the incidence of patellar crepitus complication and the clinical outcome between remove and not remove fibrosynovial tissue at the border of the superior pole of the patellar in posterior stabilized total knee arthroplasty.

02

Conditions studied

  • Removal of Fibrosynovial Tissue
  • Non-removal of Fibrosynovial Tissue
  • Patellar Non-resurfacing
03

In context

Lead sponsor

Navamindradhiraj University is the lead sponsor of 14 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary osteoarthritis of knee who were scheduled for a primary total knee arthroplasty

Exclusion criteria

Exclusion Criteria:

  • Valgus deformity
  • History of inflammatory arthroplathy
  • Previous fracture or open surgery on the same knee
  • History of patellar instability
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
138 participants (actual)

Study arms

  • Experimental
    Removal of fibrosynovial tissue

    Removal of fibrosynovial tissue in patellar non-resurfacing TKA

    Procedure: Removal of fibrosynovial tissue

  • Experimental
    Non-removal of fibrosynovial tissue

    Non-removal of fibrosynovial tissue in patellar non-resurfacing TKA

    Procedure: Non-removal of fibrosynovial tissue

Interventions

  • ProcedureRemoval of fibrosynovial tissue

    Remove of fibrosynovial tissue at the superior border of patella

  • ProcedureNon-removal of fibrosynovial tissue

    Do not remove of fibrosynovial tissue at the superior border of patella

06

What researchers measure

Primary outcomes

  1. Incidence of patellar crepitus complication

    Incidence of patellar crepitus complication (present, absent)

    Time frame: Change from baseline patellar crepitus complication 3 months, 6 months, and 12 months after surgery

Secondary outcomes

  1. Knee Society and Knee Society function score

    Knee Society and Knee Society function score (minimum 0, maximum 200)

    Time frame: Change from baseline Knee Society and Knee Society function score at 3 months, 6 months, and 12 months after surgery

  2. New patellar score

    New patellar score (minimum 0, maximum 30)

    Time frame: Change from baseline new patellar score at 3 months, 6 months, and 12 months after surgery

  3. Oxford knee score

    Oxford knee score (minimum 0, maximum 48)

    Time frame: Change from baseline Oxford knee score 3 months, 6 months, and 12 months after surgery

  4. Change of post-operative anterior knee pain

    Visual Analog Scale for anterior knee pain (minimum 0, maximum 10) Do higher values represent a worse outcome

    Time frame: Change from baseline Visual Analog Scale for anterior knee pain at 3 months, 6 months, and 12 months after surgery

07

Study locations

1 site
  • Navamindradhiraj University
    Dusit, Bangkok, 10300, Thailand
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2020 (actual). Primary completion is estimated for Jul 2022, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2020
First posted
Jun 12, 2020
StartActual
Jun 10, 2020
Primary completionEst.
Jul 2022
CompletionEst.
Dec 2022
Last update
Aug 31, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04429997
Lead sponsor
Navamindradhiraj University
Responsible party
Satit Thiengwittayaporn (Associate Professor, Navamindradhiraj University) — Principal investigator
First posted
Jun 12, 2020
Start date
Jun 10, 2020
Primary completion
Jul 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Aug 31, 2021

Study contacts

Satit Thiengwittayaporn, M.D.
principal investigator · Department of Orthopaedics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion